So just to summarize the key takeaways for the third quarter, strong top-line growth in both Proprietary and Contract Manufacturing, gross profit margin improvement, growth in operating profit margin, growth in adjusted diluted earnings per share and growth in operating and free cash flow.
As for guidance for the remainder of the year, we are confident that we're well positioned with the strength and resiliency of our core underlying business and the incremental opportunities being presented to support our customers with pandemic solutions.
Our adjusted operating profit margin of 19% was a 360 basis point increase from the same period last year.
And we've had over 18% organic sales growth in the third quarter, driven again by robust high value product sales, as well as sales in contract manufacturing.
COVID-related net revenues are estimated to have been approximately $32 million in the quarter.
